Cargando…

The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models

BACKGROUND: Many studies indicate that gallstone formation has genetic components. The abnormal expression of lipid-related genes could be the basis for particular forms of cholesterol gallstone disease. The aim of this study was to obtain insight into lipid metabolism disorder during cholesterol ga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Ning, Meng, Ke, Zhang, Yuqing, Hu, Yong, Li, Donghua, Gao, Qiaoying, Wang, Jianhua, Li, Yanning, Wu, Shangwei, Cui, Yunfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333299/ https://www.ncbi.nlm.nih.gov/pubmed/32615989 http://dx.doi.org/10.1186/s12944-020-01334-3

Ejemplares similares

Protective Effects of Yinchenhao Decoction on Cholesterol Gallstone in Mice Fed a Lithogenic Diet by Regulating LXR, CYP7A1, CYP7B1, and HMGCR Pathways
por: Meng, Yong, et al.
Publicado: (2018)

Ursodeoxycholic acid lowers bile lithogenicity by regulating SCP2 expression in rabbit cholesterol gallstone models
por: Cui, Yunfeng, et al.
Publicado: (2012)

Overexpression of Sterol Carrier Protein 2 in Patients with Hereditary Cholesterol Gallstones
por: Cui, YunFeng, et al.
Publicado: (2011)

Combination treatment with n-3 polyunsaturated fatty acids and ursodeoxycholic acid dissolves cholesterol gallstones in mice
por: Jang, Sung Ill, et al.
Publicado: (2019)

Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans
por: Tuncer, Ilyas, et al.
Publicado: (2012)

Ursodeoxycholic acid in the management of symptomatic gallstone disease: systematic review and clinician survey
por: Hall, Lewis, et al.
Publicado: (2023)

Serum lipid concentrations in patients with cholesterol and pigment gallstones
por: Weerakoon, Harshi Thilanka Welegedara, et al.
Publicado: (2014)

Ursodeoxycholic acid in the prevention of gallstones in patients subjected to Roux-en-Y gastric bypass
por: Machado, Francisco Heine Ferreira, et al.
Publicado: (2019)

Pathogenesis of Cholesterol Gallstones
por: Strasberg, Steven M., et al.
Publicado: (1991)

Prevention of Gallstones After Bariatric Surgery using Ursodeoxycholic Acid: A Narrative Review of Literatures
por: Son, Sang-Yong, et al.
Publicado: (2022)

Efficacy of Magnesium Trihydrate of Ursodeoxycholic Acid and Chenodeoxycholic Acid for Gallstone Dissolution: A Prospective Multicenter Trial
por: Hyun, Jong Jin, et al.
Publicado: (2015)

Ursodeoxycholic acid combined with percutaneous transhepatic balloon dilation for management of gallstones after elimination of common bile duct stones
por: Chang, Hai-Yang, et al.
Publicado: (2018)

Circadian Rhythm Disruption Influenced Hepatic Lipid Metabolism, Gut Microbiota and Promoted Cholesterol Gallstone Formation in Mice
por: He, Chuanqi, et al.
Publicado: (2021)

Osteopontin and integrin are involved in cholesterol gallstone formation
por: Yang, Lin, et al.
Publicado: (2012)

Gypenosides Prevent and Dissolve Cholesterol Gallstones by Modulating the Homeostasis of Cholesterol and Bile Acids
por: Zhuang, Qian, et al.
Publicado: (2022)

Association Study Between Polymorphic Loci in Cholesterol Metabolism Pathway and Gallstone in the Tibetan Population
por: Ma, Lifeng, et al.
Publicado: (2022)

FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by Lactobacillus Strains
por: Ye, Xin, et al.
Publicado: (2022)

Recent advances in understanding and managing cholesterol gallstones
por: Di Ciaula, Agostino, et al.
Publicado: (2018)

Relation of cholesterol metabolism to pediatric gallstone disease: a retrospective controlled study
por: Koivusalo, Antti, et al.
Publicado: (2015)

Cholesterol gallstones: Focusing on the role of interstitial Cajal-like cells
por: Fu, Bei-Bei, et al.
Publicado: (2021)

The effects of serum cholesterol, LDL, and HDL levels on gallstone cholesterol concentration
por: Atamanalp, S. Selcuk, et al.
Publicado: (2013)

Distinct lipid profile in haemolytic anaemia-related gallstones compared with the general gallstone
por: Wan, Ziqi, et al.
Publicado: (2023)

miRNA-223 Suppresses Mouse Gallstone Formation by Targeting Key Transporters in Hepatobiliary Cholesterol Secretion Pathway
por: Zhao, Feng, et al.
Publicado: (2021)

Current Views on Genetics and Epigenetics of Cholesterol Gallstone Disease
por: Di Ciaula, Agostino, et al.
Publicado: (2013)

An Analysis of the Role of the Indigenous Microbiota in Cholesterol Gallstone Pathogenesis
por: Fremont-Rahl, Jacqueline J., et al.
Publicado: (2013)

Metagenomics of pigmented and cholesterol gallstones: the putative role of bacteria
por: Kose, S. H., et al.
Publicado: (2018)

Blood lipid metabolism and the risk of gallstone disease: a multi-center study and meta-analysis
por: Zhang, Min, et al.
Publicado: (2022)

Ezetimibe in Combination With Simvastatin Reduces Remnant Cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients
por: Ahmed, Osman, et al.
Publicado: (2018)

Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial)
por: Boerlage, Thomas C. C., et al.
Publicado: (2017)

Efficacy and Safety of Ursodeoxycholic Acid for the Prevention of Gallstone Formation After Gastrectomy in Patients With Gastric Cancer: The PEGASUS-D Randomized Clinical Trial
por: Lee, Sang Hyub, et al.
Publicado: (2020)

Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery
por: Haal, Sylke, et al.
Publicado: (2022)

Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion
por: Hu, Hai, et al.
Publicado: (2022)

Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial)
por: Haal, Sylke, et al.
Publicado: (2020)

The Expression of Hepatic Carboxypeptidase E is Decreased in Patients with Cholesterol Gallstone
por: Dai, Shu-Long, et al.
Publicado: (2015)

Alteration of gut microbiota in association with cholesterol gallstone formation in mice
por: Wang, Qihan, et al.
Publicado: (2017)

The association between gut microbiota, cholesterol gallstones, and colorectal cancer
por: Rezasoltani, Sama, et al.
Publicado: (2019)

Research progress on the immune microenvironment of the gallbladder in patients with cholesterol gallstones
por: Jiao, Jing-Yi, et al.
Publicado: (2022)

Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
por: Mueller, Michaela, et al.
Publicado: (2015)

Copy number variants in lipid metabolism genes are associated with gallstones disease in men
por: Pérez-Palma, Eduardo, et al.
Publicado: (2019)

Ursodeoxycholic Acid Ameliorates Fructose-Induced Metabolic Syndrome in Rats
por: Mahmoud, Amr A. A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ov3bbkcooi4gn2pl4v7v6kadia